5–7 predominant half lives [Design Issues]

posted by Helmut Homepage – Vienna, Austria, 2018-05-03 14:12  – Posting: # 18754
Views: 1,039

Hi Rajasekhar,

» Example: Tamsulosin
» how to fix number of days to dosing

Until (pseudo) steady state is achieved. See this post for an example of linear PK.
Which regulation are you “targeting”? For the FDA a multiple dose study is not required. Since the SmPC recommends intake after breakfast, according to the EMA’s GL the multiple dose study has to be performed in fed state.

» how to fix number of doses per day

According to the posology of the reference (for tamsulosin OAD after breakfast).

» My regular practice is if label/smpc states achievement of steady-state concentrations by the fifth day of once-a-day dosing for Tamsulosin, i will design the study state protocol with once a day dosing for five days.

Fine but copy/paste ≠ science. :-D

» […] i want to know the exact scientific rationale behind this.

Kudos. Steady state is practically reached after 5–7 predominant half lives (96.9–99.2% of theoretical steady state). Note that Flomax® is a CR-formulation (flip-flop PK, where ka < ke). Whereas the elimination half life (after IV or IR) is ~6–7 hours, the apparent one of the CR is substantially prolonged (see the FDA’s NDA approval; page 217 of the PDF).

For drugs with nonlinear PK (e.g., saturation of metabolizing enzymes, auto-induction or -inhibition) it is complicated. Consult with a pharmacokineticist.

Helmut Schütz

The quality of responses received is directly proportional to the quality of the question asked. ☼
Science Quotes

Complete thread:

 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
19,607 posts in 4,159 threads, 1,340 registered users;
online 7 (0 registered, 7 guests [including 4 identified bots]).
Forum time (Europe/Vienna): 05:25 CEST

Every sentence I utter must be understood
not as an affirmation
but as a question.    Niels Bohr

BEBAC Ing. Helmut Schütz